NEW YORK (360Dx) – Aushon BioSystems and RDL Reference Laboratory today announced a collaboration that includes the use of Aushon's multiplexing platform.

RDL has adopted Aushon's Cira technology for the simultaneous measurement of protein biomarker panels for the early detection and measurement of disease activity in several autoimmune indications. RDL will also offer Aushon's test menu as part of its newly expanded contract research organization services, and develop its own diagnostic assays using Aushon's platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.